Barcelona, Sally .

HRN: 26-16-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/01/2024
12/07/2024
IV
500 Mg
Q8
Cholelithiasis
Waiting Final Action 
12/01/2024
CEFTRIAXONE 1G (VIAL)
12/01/2024
12/07/2024
IV
2g
Q24
Cholelithiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: